Molecular Classification of Endometrial Cancer and the 2023 FIGO Staging: Exploring the Challenges and Opportunities for Pathologists

Molecular Classification of Endometrial Cancer and the 2023 FIGO Staging: Exploring the Challenges and Opportunities for Pathologists

This commentary explores the complexities of the FIGO 2023 staging system and the inclusion of The Cancer Genome Atlas’s (TCGA) molecular classification in the management of endometrial cancer. It highlights the importance of histology as a prognostic tool, while scrutinizing the merits and demerits...

Full description

Bibliographic Details
Main Author:	Wenxin Zheng
Format:	Article
Language:	English
Published:	MDPI AG 2023-08-01
Series:	Cancers
Subjects:	endometrial cancer FIGO staging molecular classification TCGA-EC POLE mutations
Online Access:	https://www.mdpi.com/2072-6694/15/16/4101

Similar Items

Risk Stratification of Endometrial Cancer Patients: FIGO Stage, Biomarkers and Molecular Classification
by: Jenneke C. Kasius, et al.
Published: (2021-11-01)

Prognosis of Stage I Endometrial Cancer According to the FIGO 2023 Classification Taking into Account Molecular Changes
by: Bozena Dobrzycka, et al.
Published: (2024-01-01)

Impact of the 2023 FIGO Staging System for Endometrial Cancer on the Use of Imaging Services: An Indian Perspective
by: Anuradha Chandramohan, et al.
Published: (2024-04-01)

Outcomes of “sandwich” chemoradiotherapy compared with chemotherapy alone for the adjuvant treatment of FIGO stage III endometrial cancer
by: Shao-Jing Wang, et al.
Published: (2022-09-01)

Influence of New FIGO 2018 Staging on Treatment Outcomes in Early-Stage Cervical Cancer: A Single-Center Study
by: Satinder Kaur, et al.
Published: (2022-07-01)

Number of Positive Lymph Nodes and Survival in Endometrial Carcinoma: A Proposal for a Modified Staging
by: Li L, et al.
Published: (2024-01-01)

Survival rate of endometrial cancer patients at Phramongkutklao Hospital
by: Sansanee Payanta, et al.
Published: (2016-06-01)

Diagnostic value of integrated 18F-FDG PET/MRI for staging of endometrial carcinoma: comparison with PET/CT
by: Yang Yu, et al.
Published: (2022-09-01)

Vulvar Cancer: 2021 Revised FIGO Staging System and the Role of Imaging
by: Mayur Virarkar, et al.
Published: (2022-04-01)

Application of the “Hand as Foot” teaching method in the endometrial carcinoma
by: Xiaole Wang, et al.
Published: (2022-04-01)

Endometrial clear cell carcinoma: A population-based study
by: Pengfei Cui, et al.
Published: (2022-10-01)

Czy zamienne stosowanie klasyfikacji zaawansowania nowotworów endometrium według Międzynarodowej Federacji Ginekologów i Położników z 1988 roku i z 2009 roku może prowadzić do istotnych pomyłek klinicznych?
by: Jarosław Szwalski, et al.
Published: (2011-10-01)

Validation of the 2018 FIGO Staging System of Cervical Cancer for Stage III Patients with a Cohort from China
by: Liu X, et al.
Published: (2020-02-01)

Construction of refined staging classification systems integrating FIGO/T‐categories and corpus uterine invasion for non‐metastatic cervical cancer
by: Xiao‐Dan Huang, et al.
Published: (2023-07-01)

Incidence of positive peritoneal cytology in patients with endometrial carcinoma after hysteroscopy vs. dilatation and curettage
by: Dovnik Andraz, et al.
Published: (2016-02-01)

Imaging in Carcinoma Cervix and Revised 2018 FIGO Staging System: Implications in Radiology Reporting
by: Ekta Dhamija, et al.
Published: (2021-07-01)

Should the Number of Metastatic Pelvic Lymph Nodes Be Integrated into the 2018 Figo Staging Classification of Early Stage Cervical Cancer?
by: Luigi Pedone Anchora, et al.
Published: (2020-06-01)

Nomograms Predicting Survival of Cervical Cancer Patients Treated With Concurrent Chemoradiotherapy Based on the 2018 FIGO Staging System
by: Qingyu Meng, et al.
Published: (2022-05-01)

The Clinical and Pathological Characteristics of POLE-Mutated Endometrial Cancer: A Comprehensive Review
by: Yao X, et al.
Published: (2024-03-01)

Radiology–pathology correlation of endometrial carcinoma assessment on magnetic resonance imaging
by: Eveline Dokter, et al.
Published: (2022-04-01)

The cancer genome atlas - TCGA molecular classification: A changing paradigm in the management of endometrial cancers
by: Rahul Deepak Modi
Published: (2023-01-01)

A retrospective analysis for investigating the relationship between FIGO stage IVA/IVB and cytoreductive surgery with prognosis in epithelial ovarian cancer
by: Hong Liu, et al.
Published: (2023-07-01)

Emerging Advances in Endometrial Cancer: Integration of Molecular Classification into Staging for Enhanced Prognostic Accuracy and Implications for Racial Disparities
by: Joy Ogunmuyiwa, et al.
Published: (2024-03-01)

Treatment of FIGO 2018 stage IIIC cervical cancer with different local tumor factors
by: Yanna Ye, et al.
Published: (2023-05-01)

Clinical Significance, Cellular Function, and Potential Molecular Pathways of CCT7 in Endometrial Cancer
by: Liwen Wang, et al.
Published: (2020-08-01)

Molecular-based classification of endometrial carcinoma in Northern Thailand: impact on prognosis and potential for implementation in resource-limited settings
by: Wiyada Dankai, et al.
Published: (2023-11-01)

Diagnostic Value of Dynamic Magnetic Resonance Imaging with Diffusion Weighted Imaging in the Staging of Endometrial Carcinoma
by: Farokh Seilanian Toosi, et al.
Published: (2022-07-01)

Epigenetic changes as prognostic predictors in endometrial carcinomas
by: Sanja A. Farkas, et al.
Published: (2017-01-01)

Increased incidence and improved survival in endometrial cancer in Sweden 1960–2014: a population-based registry survey
by: Filip Herbst, et al.
Published: (2023-03-01)

E-cadherin and CD10 expression in atypical hyperplastic and malignant endometrial lesions
by: Ahmed R.H. Ahmed, et al.
Published: (2014-12-01)

A Suggested Modification to FIGO Stage IV Epithelial Ovarian Cancer
by: Marie Métairie, et al.
Published: (2023-01-01)

CARACTERIZACIÓN DE 1.131 PACIENTES CON CÁNCER CÉRVICO-UTERINO SEGÚN ESTADIO FIGO: HOSPITAL GUILLERMO GRANT, 1999-2005
by: Jorge Cabrera D, et al.
Published: (2009-01-01)

The Advantages of Next-Generation Sequencing Molecular Classification in Endometrial Cancer Diagnosis
by: Daniela Rivera, et al.
Published: (2023-11-01)

Validation of the 2018 FIGO Classification for Cervical Cancer: Lymphovascular Space Invasion Should Be Considered in IB1 Stage
by: Vincent Balaya, et al.
Published: (2020-11-01)

FIGO 2018 Staging for Cervical Cancer: Influence on Stage Distribution and Outcomes in the 3D-Image-Guided Brachytherapy Era
by: Kento Tomizawa, et al.
Published: (2020-07-01)

Spatial distribution of CD3- and CD8-positive lymphocytes as pretest for POLE wild-type in molecular subgroups of endometrial carcinoma
by: Samuel H. Jungen, et al.
Published: (2023-03-01)

Does the New FIGO 2018 Staging System Allow Better Prognostic Differentiation in Early Stage Cervical Cancer? A Dutch Nationwide Cohort Study
by: Mieke L. G. Ten Eikelder, et al.
Published: (2022-06-01)

Molecular Classification to Prognosticate Response in Medically Managed Endometrial Cancers and Endometrial Intraepithelial Neoplasia
by: Allison M. Puechl, et al.
Published: (2021-06-01)

Prognostic Nomograms Predicting Survival in Patients With Locally Advanced Cervical Squamous Cell Carcinoma: The First Nomogram Compared With Revised FIGO 2018 Staging System
by: Xi Yang, et al.
Published: (2020-10-01)

The role of TCGA molecular classification in clear cell endometrial carcinoma
by: Xinyue Tang, et al.
Published: (2023-06-01)